1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Gastroesophageal Reflux
Nantes University HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Gastroesophageal Reflux cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lansoprazole Children's Mercy Hospital Kansas City | Phase 4 | BB |
PANTOPRAZOLE Children's Mercy Hospital Kansas City | Phase 4 | BB |
MIDAZOLAM Children's Mercy Hospital Kansas City | Phase 4 | BB |
Dexlansoprazole National Cheng-Kung University Hospital | Phase 4 | BB |
LIDOCAINE Hospital Infantil Cândido Fontoura | Phase 3 | BB |
View all 17 →
Same molecule, other indications
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →